GE Healthcare Medical Diagnostics
GE Healthcare Medical Diagnostics Re-launches Optison Contrast Agent
Published in Medical Letter on the CDC and FDA, August 1st, 2010
GE Healthcare Medical Diagnostics announced the market reintroduction of Optison™ (Perflutren Protein-Type A Microspheres Injectable Suspension, USP), a diagnostic ultrasound contrast agent for use in select echocardiograms. Optison is indicated for use in patients with suboptimal echocardiograms to opacify the left ventricle and to improve the delineation of the left ventricular endocardial borders. The safety and efficacy of Optison with exercise stress or pharmacologic stress testing have not been established.
"We are excited to announce the reintroduction of Optison," said Kimberly Wolf, Regional Marketing Leader - Americas, GE Healthcare Medical Diagnostics....
Want to see the full article?
We're a pay-per-view site for premium content. If you'd like to purchase this article, it's only $3.00.
Welcome to NewsRx!
Learn more about a six-week, no-risk free trial of Medical Letter on the CDC and FDA
More Articles from Medical Letter on the CDC and FDA
- U.S. Food and Drug Administration
FDA GRAS Confirmed Amino Acid from Ajinomoto Now Available As Key Ingredient for Food and Beverage Manufacturers - U.S. Food and Drug Administration
Federal Agents Seize Bee-Shield Hand Sanitizer from Puerto Rican Company - Bartonella
Research on bartonella published by M. Kosoy et al - Fibrosis
Research on fibrosis detailed by scientists at National Institute for Occupational Safety and Health - Infection Control
Cintas Announces Top 5 Things Infection Preventionists Should Know about Their Hospital's Microfiber Program - Shiga Toxin
Federal Agencies Announce Progress in First Year of Implementing Food Safety Working Group Recommendations - More from this issue of Medical Letter on the CDC and FDA
NewsRx is Social
Follow us on your favorite social network by clicking on a button below:
Top Medical Newsletters
Awards
Best Health/Healthcare Content, 2012
Best Health/Healthcare Content, 2011
Best e-Business Site, 2010
Best e-Business Site, 2009
Best e-Business Site, 2008
Best e-Business Site, 2007
Best e-Business Site, 2006
Best Healthcare Content, 2005
Best Overall Internet Site, 2005
Best Interactive Site, 2005
Facts & Stats
NewsRx also is available at LexisNexis, Gale, ProQuest, Factiva, Dialog, Thomson Reuters, NewsEdge, and Dow Jones.
- Google 2010 PageRank: #2 Among Top Health News and Media Publications
- Google 2010 PageRank: #2 Among Top Science Publications in Biology/Physiology
- Google 2010 PageRank: #2 Among Top News and Media for the Business of Pharmaceuticals
- Amazon's Alexa 2010 PageRank: #2 News and Media Site for the Pharmaceutical Industry
